BIOGEN INC.·4

Feb 14, 6:17 PM ET

McKenzie Paul 4

4 · BIOGEN INC. · Filed Feb 14, 2019

Insider Transaction Report

Form 4
Period: 2019-02-12
McKenzie Paul
EVP Pharmaceutical Oper & Tech
Transactions
  • Exercise/Conversion

    Common Stock

    2019-02-12+1,2635,639.631 total
  • Tax Payment

    Common Stock

    2019-02-12$319.43/sh380$121,3835,259.631 total
  • Exercise/Conversion

    Common Stock

    2019-02-12+1,7997,058.631 total
  • Tax Payment

    Common Stock

    2019-02-12$319.43/sh539$172,1736,519.631 total
  • Exercise/Conversion

    Restricted Stock Unit

    2019-02-121,2632,527 total
    Exercise: $0.00Exp: 2020-02-12Common Stock (1,263 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2019-02-121,7997,671 total
    Exercise: $0.00Exp: 2021-02-12Common Stock (1,799 underlying)
  • Other

    Restricted Stock Unit

    2019-02-121,3576,314 total
    Exercise: $0.00Exp: 2021-02-12Common Stock (1,357 underlying)
  • Award

    Restricted Stock Unit

    2019-02-12+10,96010,960 total
    Exercise: $0.00Exp: 2022-02-12Common Stock (10,960 underlying)
Footnotes (4)
  • [F1]Includes 74.812 shares acquired under the Biogen Inc. employee stock purchase plan on 3/29/2018.
  • [F2]The restricted stock units will vest in 2 annual installments. One-third will vest on the first anniversary of the grant date and two-thirds will vest on the second anniversary of the grant date.
  • [F3]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
  • [F4]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT